Cargando…
IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
IL-17-producing CD8(+) (Tc17) cells are enriched in active lesions of patients with multiple sclerosis (MS), suggesting a role in the pathogenesis of autoimmunity. Here we show that amelioration of MS by dimethyl fumarate (DMF), a mechanistically elusive drug, associates with suppression of Tc17 cel...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915776/ https://www.ncbi.nlm.nih.gov/pubmed/31844089 http://dx.doi.org/10.1038/s41467-019-13731-z |
_version_ | 1783480095108759552 |
---|---|
author | Lückel, Christina Picard, Felix Raifer, Hartmann Campos Carrascosa, Lucia Guralnik, Anna Zhang, Yajuan Klein, Matthias Bittner, Stefan Steffen, Falk Moos, Sonja Marini, Federico Gloury, Renee Kurschus, Florian C. Chao, Ying-Yin Bertrams, Wilhelm Sexl, Veronika Schmeck, Bernd Bonetti, Lynn Grusdat, Melanie Lohoff, Michael Zielinski, Christina E. Zipp, Frauke Kallies, Axel Brenner, Dirk Berger, Michael Bopp, Tobias Tackenberg, Björn Huber, Magdalena |
author_facet | Lückel, Christina Picard, Felix Raifer, Hartmann Campos Carrascosa, Lucia Guralnik, Anna Zhang, Yajuan Klein, Matthias Bittner, Stefan Steffen, Falk Moos, Sonja Marini, Federico Gloury, Renee Kurschus, Florian C. Chao, Ying-Yin Bertrams, Wilhelm Sexl, Veronika Schmeck, Bernd Bonetti, Lynn Grusdat, Melanie Lohoff, Michael Zielinski, Christina E. Zipp, Frauke Kallies, Axel Brenner, Dirk Berger, Michael Bopp, Tobias Tackenberg, Björn Huber, Magdalena |
author_sort | Lückel, Christina |
collection | PubMed |
description | IL-17-producing CD8(+) (Tc17) cells are enriched in active lesions of patients with multiple sclerosis (MS), suggesting a role in the pathogenesis of autoimmunity. Here we show that amelioration of MS by dimethyl fumarate (DMF), a mechanistically elusive drug, associates with suppression of Tc17 cells. DMF treatment results in reduced frequency of Tc17, contrary to Th17 cells, and in a decreased ratio of the regulators RORC-to-TBX21, along with a shift towards cytotoxic T lymphocyte gene expression signature in CD8(+) T cells from MS patients. Mechanistically, DMF potentiates the PI3K-AKT-FOXO1-T-BET pathway, thereby limiting IL-17 and RORγt expression as well as STAT5-signaling in a glutathione-dependent manner. This results in chromatin remodeling at the Il17 locus. Consequently, T-BET-deficiency in mice or inhibition of PI3K-AKT, STAT5 or reactive oxygen species prevents DMF-mediated Tc17 suppression. Overall, our data disclose a DMF-AKT-T-BET driven immune modulation and suggest putative therapy targets in MS and beyond. |
format | Online Article Text |
id | pubmed-6915776 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69157762019-12-18 IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis Lückel, Christina Picard, Felix Raifer, Hartmann Campos Carrascosa, Lucia Guralnik, Anna Zhang, Yajuan Klein, Matthias Bittner, Stefan Steffen, Falk Moos, Sonja Marini, Federico Gloury, Renee Kurschus, Florian C. Chao, Ying-Yin Bertrams, Wilhelm Sexl, Veronika Schmeck, Bernd Bonetti, Lynn Grusdat, Melanie Lohoff, Michael Zielinski, Christina E. Zipp, Frauke Kallies, Axel Brenner, Dirk Berger, Michael Bopp, Tobias Tackenberg, Björn Huber, Magdalena Nat Commun Article IL-17-producing CD8(+) (Tc17) cells are enriched in active lesions of patients with multiple sclerosis (MS), suggesting a role in the pathogenesis of autoimmunity. Here we show that amelioration of MS by dimethyl fumarate (DMF), a mechanistically elusive drug, associates with suppression of Tc17 cells. DMF treatment results in reduced frequency of Tc17, contrary to Th17 cells, and in a decreased ratio of the regulators RORC-to-TBX21, along with a shift towards cytotoxic T lymphocyte gene expression signature in CD8(+) T cells from MS patients. Mechanistically, DMF potentiates the PI3K-AKT-FOXO1-T-BET pathway, thereby limiting IL-17 and RORγt expression as well as STAT5-signaling in a glutathione-dependent manner. This results in chromatin remodeling at the Il17 locus. Consequently, T-BET-deficiency in mice or inhibition of PI3K-AKT, STAT5 or reactive oxygen species prevents DMF-mediated Tc17 suppression. Overall, our data disclose a DMF-AKT-T-BET driven immune modulation and suggest putative therapy targets in MS and beyond. Nature Publishing Group UK 2019-12-16 /pmc/articles/PMC6915776/ /pubmed/31844089 http://dx.doi.org/10.1038/s41467-019-13731-z Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lückel, Christina Picard, Felix Raifer, Hartmann Campos Carrascosa, Lucia Guralnik, Anna Zhang, Yajuan Klein, Matthias Bittner, Stefan Steffen, Falk Moos, Sonja Marini, Federico Gloury, Renee Kurschus, Florian C. Chao, Ying-Yin Bertrams, Wilhelm Sexl, Veronika Schmeck, Bernd Bonetti, Lynn Grusdat, Melanie Lohoff, Michael Zielinski, Christina E. Zipp, Frauke Kallies, Axel Brenner, Dirk Berger, Michael Bopp, Tobias Tackenberg, Björn Huber, Magdalena IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title | IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_full | IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_fullStr | IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_full_unstemmed | IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_short | IL-17(+) CD8(+) T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
title_sort | il-17(+) cd8(+) t cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915776/ https://www.ncbi.nlm.nih.gov/pubmed/31844089 http://dx.doi.org/10.1038/s41467-019-13731-z |
work_keys_str_mv | AT luckelchristina il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT picardfelix il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT raiferhartmann il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT camposcarrascosalucia il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT guralnikanna il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT zhangyajuan il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT kleinmatthias il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bittnerstefan il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT steffenfalk il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT moossonja il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT marinifederico il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT glouryrenee il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT kurschusflorianc il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT chaoyingyin il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bertramswilhelm il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT sexlveronika il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT schmeckbernd il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bonettilynn il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT grusdatmelanie il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT lohoffmichael il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT zielinskichristinae il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT zippfrauke il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT kalliesaxel il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT brennerdirk il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bergermichael il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT bopptobias il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT tackenbergbjorn il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis AT hubermagdalena il17cd8tcellsuppressionbydimethylfumarateassociateswithclinicalresponseinmultiplesclerosis |